101 related articles for article (PubMed ID: 31758088)
1. Correction: Transient stabilization, rather than inhibition, of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma.
Harrington CT; Sotillo E; Robert A; Hayer KE; Bogusz AM; Psathas J; Yu D; Taylor D; Dang CV; Klein PS; Hogarty MD; Geoerger B; El-Deiry WS; Wiels J; Thomas-Tikhonenko A
Leukemia; 2020 May; 34(5):1485. PubMed ID: 31758088
[TBL] [Abstract][Full Text] [Related]
2. Transient stabilization, rather than inhibition, of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma.
Harrington CT; Sotillo E; Robert A; Hayer KE; Bogusz AM; Psathas J; Yu D; Taylor D; Dang CV; Klein PS; Hogarty MD; Geoerger B; El-Deiry WS; Wiels J; Thomas-Tikhonenko A
Leukemia; 2019 Oct; 33(10):2429-2441. PubMed ID: 30914792
[TBL] [Abstract][Full Text] [Related]
3. Author Correction: TRAF3 regulates the oncogenic proteins Pim2 and c-Myc to restrain survival in normal and malignant B cells.
Whillock AL; Mambetsariev N; Lin WW; Stunz LL; Bishop GA
Sci Rep; 2019 Nov; 9(1):17502. PubMed ID: 31745166
[TBL] [Abstract][Full Text] [Related]
4. Correction: Immune profiling in diffuse large B-cell lymphoma and mantle cell lymphoma patients treated with autologous hematopoietic cell transplant.
Herr MM; Torka P; Zhang Y; Wallace PK; Tario JD; Repasky EA; Chen GL; Ho CM; Balderman SR; Ross M; Paiva B; Hernandez-Ilizaliturri FJ; McCarthy PL; Hahn T
Bone Marrow Transplant; 2020 Jan; 55(1):272. PubMed ID: 31471573
[TBL] [Abstract][Full Text] [Related]
5. Correction: Plakophilin 1 enhances MYC translation, promoting squamous cell lung cancer.
Martin-Padron J; Boyero L; Rodriguez MI; Andrades A; Díaz-Cano I; Peinado P; Baliñas-Gavira C; Alvarez-Perez JC; Coira IF; Fárez-Vidal ME; Medina PP
Oncogene; 2020 Aug; 39(32):5494. PubMed ID: 31937909
[TBL] [Abstract][Full Text] [Related]
6. Author Correction: Stabilization of SIRT7 deacetylase by viral oncoprotein HBx leads to inhibition of growth restrictive RPS7 gene and facilitates cellular transformation.
Pandey V; Kumar V
Sci Rep; 2020 Jun; 10(1):10860. PubMed ID: 32601345
[TBL] [Abstract][Full Text] [Related]
7. Correction to: Adenovirus-mediated LIGHT gene modification in murine B-cell lymphoma elicits a potent antitumor effect.
Hu G; Liu Y; Li H; Zhao D; Yang L; Shen J; Hong X; Cao X; Wang Q
Cell Mol Immunol; 2020 Mar; 17(3):305-306. PubMed ID: 32071419
[TBL] [Abstract][Full Text] [Related]
8. Author Correction: Lineage-specific RUNX2 super-enhancer activates MYC and promotes the development of blastic plasmacytoid dendritic cell neoplasm.
Kubota S; Tokunaga K; Umezu T; Yokomizo-Nakano T; Sun Y; Oshima M; Tan KT; Yang H; Kanai A; Iwanaga E; Asou N; Maeda T; Nakagata N; Iwama A; Ohyashiki K; Osato M; Sashida G
Nat Commun; 2019 Aug; 10(1):3943. PubMed ID: 31462675
[TBL] [Abstract][Full Text] [Related]
9. Author Correction: Safety and feasibility of anti-CD19 CAR T cells with fully human binding domains in patients with B-cell lymphoma.
Brudno JN; Lam N; Vanasse D; Shen YW; Rose JJ; Rossi J; Xue A; Bot A; Scholler N; Mikkilineni L; Roschewski M; Dean R; Cachau R; Youkharibache P; Patel R; Hansen B; Stroncek DF; Rosenberg SA; Gress RE; Kochenderfer JN
Nat Med; 2020 May; 26(5):803. PubMed ID: 32291416
[TBL] [Abstract][Full Text] [Related]
10. Author Correction: WNT signaling and AHCTF1 promote oncogenic MYC expression through super-enhancer-mediated gene gating.
Scholz BA; Sumida N; de Lima CDM; Chachoua I; Martino M; Tzelepis I; Nikoshkov A; Zhao H; Mehmood R; Sifakis EG; Bhartiya D; Göndör A; Ohlsson R
Nat Genet; 2020 Nov; 52(11):1265. PubMed ID: 32948851
[TBL] [Abstract][Full Text] [Related]
11. Author Correction: Cyclocarya paliurus tea leaves enhances pancreatic β cell preservation through inhibition of apoptosis.
Xiao HT; Wen B; Ning ZW; Zhai LX; Liao CH; Lin CY; Mu HX; Bian ZX
Sci Rep; 2020 Nov; 10(1):19446. PubMed ID: 33149142
[TBL] [Abstract][Full Text] [Related]
12. Author Correction: Microbial spatial footprint as a driver of soil carbon stabilization.
Kravchenko AN; Guber AK; Razavi BS; Koestel J; Quigley MY; Robertson GP; Kuzyakov Y
Nat Commun; 2019 Sep; 10(1):4103. PubMed ID: 31488829
[TBL] [Abstract][Full Text] [Related]
13. Publisher Correction: Follicular lymphoma.
Nat Rev Dis Primers; 2020 Sep; 6(1):75. PubMed ID: 32929095
[TBL] [Abstract][Full Text] [Related]
14. Correction: Inhibition of microRNA-384-5p alleviates osteoarthritis through its effects on inhibiting apoptosis of cartilage cells via the NF-κB signaling pathway by targeting SOX9.
Zhang W; Cheng P; Hu W; Yin W; Guo F; Chen A; Huang H
Cancer Gene Ther; 2020 Nov; 27(10-11):836-837. PubMed ID: 32728207
[TBL] [Abstract][Full Text] [Related]
15. Publisher Correction: Safety and feasibility of CRISPR-edited T cells in patients with refractory non-small-cell lung cancer.
Lu Y; Xue J; Deng T; Zhou X; Yu K; Deng L; Huang M; Yi X; Liang M; Wang Y; Shen H; Tong R; Wang W; Li L; Song J; Li J; Su X; Ding Z; Gong Y; Zhu J; Wang Y; Zou B; Zhang Y; Li Y; Zhou L; Liu Y; Yu M; Wang Y; Zhang X; Yin L; Xia X; Zeng Y; Zhou Q; Ying B; Chen C; Wei Y; Li W; Mok T
Nat Med; 2020 Jul; 26(7):1149. PubMed ID: 32555427
[TBL] [Abstract][Full Text] [Related]
16. Author Correction: NICE's rejection of pembrolizumab for platinum-refractory urothelial carcinoma: is there a greater good?
Gupta S; Kamat AM
Nat Rev Urol; 2020 Sep; 17(9):540. PubMed ID: 32719534
[TBL] [Abstract][Full Text] [Related]
17. Correction: Dependency on the TYK2/STAT1/MCL1 axis in anaplastic large cell lymphoma.
Prutsch N; Gurnhofer E; Suske T; Liang HC; Schlederer M; Roos S; Wu LC; Simonitsch-Klupp I; Alvarez-Hernandez A; Kornauth C; Leone DA; Svinka J; Eferl R; Limberger T; Aufinger A; Shirsath N; Wolf P; Hielscher T; Sternberg C; Aberger F; Schmoellerl J; Stoiber D; Strobl B; Jäger U; Staber PB; Grebien F; Moriggl R; Müller M; Inghirami GG; Sanda T; Look AT; Turner SD; Kenner L; Merkel O
Leukemia; 2020 Nov; 34(11):3105. PubMed ID: 32665700
[TBL] [Abstract][Full Text] [Related]
18. Correction: Transient acute-onset tetraparesis in a COVID-19 patient.
Giorgianni A; Vinacci G; Agosti E; Cariddi LP; Mauri M; Baruzzi F; Versino M
Spinal Cord; 2020 Sep; 58(9):1045. PubMed ID: 32719526
[TBL] [Abstract][Full Text] [Related]
19. Author Correction: Immunogenomic profiling determines responses to combined PARP and PD-1 inhibition in ovarian cancer.
Färkkilä A; Gulhan DC; Casado J; Jacobson CA; Nguyen H; Kochupurakkal B; Maliga Z; Yapp C; Chen YA; Schapiro D; Zhou Y; Graham JR; Dezube BJ; Munster P; Santagata S; Garcia E; Rodig S; Lako A; Chowdhury D; Shapiro GI; Matulonis UA; Park PJ; Hautaniemi S; Sorger PK; Swisher EM; D'Andrea AD; Konstantinopoulos PA
Nat Commun; 2020 May; 11(1):2543. PubMed ID: 32424117
[TBL] [Abstract][Full Text] [Related]
20. Publisher Correction: Circulating serum HBsAg level is a biomarker for HBV-specific T and B cell responses in chronic hepatitis B patients.
Kim JH; Ghosh A; Ayithan N; Romani S; Khanam A; Park JJ; Rijnbrand R; Tang L; Sofia MJ; Kottilil S; Moore CB; Poonia B
Sci Rep; 2020 Mar; 10(1):5947. PubMed ID: 32231233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
